These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 31836723)
21. Crystal structure of a Tankyrase-Axin complex and its implications for Axin turnover and Tankyrase substrate recruitment. Morrone S; Cheng Z; Moon RT; Cong F; Xu W Proc Natl Acad Sci U S A; 2012 Jan; 109(5):1500-5. PubMed ID: 22307604 [TBL] [Abstract][Full Text] [Related]
22. Functional characterization of the poly(ADP-ribose) polymerase activity of tankyrase 1, a potential regulator of telomere length. Rippmann JF; Damm K; Schnapp A J Mol Biol; 2002 Oct; 323(2):217-24. PubMed ID: 12381316 [TBL] [Abstract][Full Text] [Related]
23. Vertebrate tankyrase domain structure and sterile alpha motif (SAM)-mediated multimerization. De Rycker M; Venkatesan RN; Wei C; Price CM Biochem J; 2003 May; 372(Pt 1):87-96. PubMed ID: 12589701 [TBL] [Abstract][Full Text] [Related]
24. Tankyrase polymerization is controlled by its sterile alpha motif and poly(ADP-ribose) polymerase domains. De Rycker M; Price CM Mol Cell Biol; 2004 Nov; 24(22):9802-12. PubMed ID: 15509784 [TBL] [Abstract][Full Text] [Related]
25. Tankyrases as modulators of pro-tumoral functions: molecular insights and therapeutic opportunities. Zamudio-Martinez E; Herrera-Campos AB; Muñoz A; Rodríguez-Vargas JM; Oliver FJ J Exp Clin Cancer Res; 2021 Apr; 40(1):144. PubMed ID: 33910596 [TBL] [Abstract][Full Text] [Related]
26. Tankyrase promotes primary precursor miRNA processing to precursor miRNA. Mizutani A; Seimiya H Biochem Biophys Res Commun; 2020 Feb; 522(4):945-951. PubMed ID: 31806370 [TBL] [Abstract][Full Text] [Related]
27. Crystal structure of a tankyrase 1-telomere repeat factor 1 complex. Li B; Qiao R; Wang Z; Zhou W; Li X; Xu W; Rao Z Acta Crystallogr F Struct Biol Commun; 2016 Apr; 72(Pt 4):320-7. PubMed ID: 27050267 [TBL] [Abstract][Full Text] [Related]
28. Tankyrase-2 oligomerizes with tankyrase-1 and binds to both TRF1 (telomere-repeat-binding factor 1) and IRAP (insulin-responsive aminopeptidase). Sbodio JI; Lodish HF; Chi NW Biochem J; 2002 Feb; 361(Pt 3):451-9. PubMed ID: 11802774 [TBL] [Abstract][Full Text] [Related]
29. Tankyrases: structure, function and therapeutic implications in cancer. Haikarainen T; Krauss S; Lehtio L Curr Pharm Des; 2014; 20(41):6472-88. PubMed ID: 24975604 [TBL] [Abstract][Full Text] [Related]
30. Tankyrase, a poly(ADP-ribose) polymerase at human telomeres. Smith S; Giriat I; Schmitt A; de Lange T Science; 1998 Nov; 282(5393):1484-7. PubMed ID: 9822378 [TBL] [Abstract][Full Text] [Related]
31. Tankyrase-targeted therapeutics: expanding opportunities in the PARP family. Riffell JL; Lord CJ; Ashworth A Nat Rev Drug Discov; 2012 Dec; 11(12):923-36. PubMed ID: 23197039 [TBL] [Abstract][Full Text] [Related]
32. Tankyrase Sterile α Motif Domain Polymerization Is Required for Its Role in Wnt Signaling. Riccio AA; McCauley M; Langelier MF; Pascal JM Structure; 2016 Sep; 24(9):1573-81. PubMed ID: 27499439 [TBL] [Abstract][Full Text] [Related]
33. Tankyrase Regulates Neurite Outgrowth through Poly(ADP-ribosyl)ation-Dependent Activation of β-Catenin Signaling. Mashimo M; Kita M; Uno A; Nii M; Ishihara M; Honda T; Gotoh-Kinoshita Y; Nomura A; Nakamura H; Murayama T; Kizu R; Fujii T Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35269974 [TBL] [Abstract][Full Text] [Related]
35. Telomere elongation by a mutant tankyrase 1 without TRF1 poly(ADP-ribosyl)ation. Muramatsu Y; Tahara H; Ono T; Tsuruo T; Seimiya H Exp Cell Res; 2008 Mar; 314(5):1115-24. PubMed ID: 18221737 [TBL] [Abstract][Full Text] [Related]
36. Identification of a tankyrase-binding motif shared by IRAP, TAB182, and human TRF1 but not mouse TRF1. NuMA contains this RXXPDG motif and is a novel tankyrase partner. Sbodio JI; Chi NW J Biol Chem; 2002 Aug; 277(35):31887-92. PubMed ID: 12080061 [TBL] [Abstract][Full Text] [Related]
37. Zoning in on Tankyrases: A Brief Review on the Past, Present and Prospective Studies. Peters XQ; Malinga TH; Agoni C; Olotu FA; Soliman MES Anticancer Agents Med Chem; 2019; 19(16):1920-1934. PubMed ID: 31648650 [TBL] [Abstract][Full Text] [Related]
38. Disruption of Wnt/β-Catenin Signaling and Telomeric Shortening Are Inextricable Consequences of Tankyrase Inhibition in Human Cells. Kulak O; Chen H; Holohan B; Wu X; He H; Borek D; Otwinowski Z; Yamaguchi K; Garofalo LA; Ma Z; Wright W; Chen C; Shay JW; Zhang X; Lum L Mol Cell Biol; 2015 Jul; 35(14):2425-35. PubMed ID: 25939383 [TBL] [Abstract][Full Text] [Related]
39. Tankyrase: a promising therapeutic target with pleiotropic action. Sagathia V; Patel C; Beladiya J; Patel S; Sheth D; Shah G Naunyn Schmiedebergs Arch Pharmacol; 2023 Dec; 396(12):3363-3374. PubMed ID: 37338576 [TBL] [Abstract][Full Text] [Related]